• Better life with AmoyDx
    more
  • Better life with AmoyDx
    more
  • AmoyDx won the Second Prize of National Scientific and Technological Progress Award
    more
  • Better life with AmoyDx
    more
Scroll

ABOUT AMOYDX

Amoy Diagnostics Co., Ltd. (AmoyDx) focuses on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS and Super-ARMS technologies, AmoyDx has a market-leading portfolio of molecular diagnostic kits including but not limited to EGFR, RAS, ALK, BRAF, PIK3CA and ROS1 testing kits, which were firstly approved by CFDA and CE certified. 

more
Better Life with AmoyDx

Latest News

Latest News more
01 /Feb

AmoyDx developed rapid detection reagent of new coronavirus, highlighting corporate social responsibility

On 31 December 2019, the WHO China Country Office was informed of cases of pneumonia unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. As of January 30, 2020, Wuhan's new coronavirus has spread rapidly across the country.

20 /Jan

AmoyDx won the Second Prize of National Scientific and Technological Progress Award and National Enterprise Technology Center

AmoyDx won the Second Prize of National Scientific and Technological Progress Award; AmoyDx Technology Center is qualified as "National Enterprise Technology Center".

25 /Nov

AmoyDx and Eisai Enter Global Diagnostic Partnership Agreement

Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE:300685), a leading company in companion diagnostics for precision oncology, today announced that recently it signed a diagnostic partnership agreement with Eisai Co., Ltd., one of leading pharmaceutical companies i

22 /Nov

AmoyDx Distributors Annual Meeting was Held in Germany

(November 21, 2019, Xiamen, China) Early this week Amoy Diagnostics Co. Ltd. (AmoyDx) distributors annual meeting 2019 was held in Dusseldorf, Germany. AmoyDx distributors from 21 countries in different continents gathered together and discussed the recen

more

New Products

new product release

    New Products

    new product release
    • Pan Lung Cancer PCR Panel

    • Multi-Gene Mutations Detection Kit

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • HANDLE HRR NGS Panel

    • PCR Pan Lung Cancer PCR Panel
      01
    • PCR Multi-Gene Mutations Detection Kit
      02
    • NGS HANDLE Classic NGS Panel
      03
    • NGS BRCA1 and BRCA2 Gene Mutation Detection Kit
      04
    • NGS HANDLE HRR NGS Panel
      05
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    • Pan Lung Cancer PCR Panel

    • Multi-Gene Mutations Detection Kit

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • HANDLE HRR NGS Panel

    • PCR Pan Lung Cancer PCR Panel
      01
    • PCR Multi-Gene Mutations Detection Kit
      02
    • NGS HANDLE Classic NGS Panel
      03
    • NGS BRCA1 and BRCA2 Gene Mutation Detection Kit
      04
    • NGS HANDLE HRR NGS Panel
      05
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    • Pan Lung Cancer PCR Panel

    • Multi-Gene Mutations Detection Kit

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • HANDLE HRR NGS Panel

    • PCR Pan Lung Cancer PCR Panel
      01
    • PCR Multi-Gene Mutations Detection Kit
      02
    • NGS HANDLE Classic NGS Panel
      03
    • NGS BRCA1 and BRCA2 Gene Mutation Detection Kit
      04
    • NGS HANDLE HRR NGS Panel
      05
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    • Pan Lung Cancer PCR Panel

    • Multi-Gene Mutations Detection Kit

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • HANDLE HRR NGS Panel

    • PCR Pan Lung Cancer PCR Panel
      01
    • PCR Multi-Gene Mutations Detection Kit
      02
    • NGS HANDLE Classic NGS Panel
      03
    • NGS BRCA1 and BRCA2 Gene Mutation Detection Kit
      04
    • NGS HANDLE HRR NGS Panel
      05
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
  1. NGS
  2. PCR
  3. FISH
  4. Extraction

AMP Annual(Association for Molecular Pathology) 2020

https://amp20.amp.org/

November 19-21, 2020
meet us

ESMO Annual Meeting 2020

https://www.esmo.org/meetings/esmo-congress-2020

September 18-22, 2020
  • Stock Info

    Stock info
  • 73.040 -0.19 -0.26%
    Stock code:300685 2020-02-27 10:06:54 Real-time data
  • View details
Inquiry
* Required information
Manage your account info
Change your password